Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (149)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Os, J.
Right arrow Articles by Verdoux, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Os, J.
Right arrow Articles by Verdoux, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2002; 156:319-327.
Copyright © 2002 by the Johns Hopkins Bloomberg School of Public Health


ORIGINAL CONTRIBUTIONS

Cannabis Use and Psychosis: A Longitudinal Population-based Study

J. van Os1,2, M. Bak1, M. Hanssen1, R. V. Bijl3,4, R. de Graaf3 and H. Verdoux5

1 Department of Psychiatry and Neuropsychology, European Graduate School of Neuroscience, Maastricht University, Maastricht, the Netherlands.
2 Division of Psychological Medicine, Institute of Psychiatry, London, United Kingdom.
3 The Netherlands Institute of Mental Health and Addiction, Trimbos-Instituut, Utrecht, the Netherlands.
4 Research and Documentation Centre (WODC), Ministry of Justice, The Hague, the Netherlands.
5 Department of Psychiatry, Victor Segalen Bordeaux 2 University, and Hôpital Charles Perrens, Bordeaux, France.

Cannabis use may increase the risk of psychotic disorders and result in a poor prognosis for those with an established vulnerability to psychosis. A 3-year follow-up (1997–1999) is reported of a general population of 4,045 psychosis-free persons and of 59 subjects in the Netherlands with a baseline diagnosis of psychotic disorder. Substance use was assessed at baseline, 1-year follow-up, and 3-year follow-up. Baseline cannabis use predicted the presence at follow-up of any level of psychotic symptoms (adjusted odds ratio (OR) = 2.76, 95% confidence interval (CI): 1.18, 6.47), as well as a severe level of psychotic symptoms (OR = 24.17, 95% CI: 5.44, 107.46), and clinician assessment of the need for care for psychotic symptoms (OR = 12.01, 95% CI: 2.24, 64.34). The effect of baseline cannabis use was stronger than the effect at 1-year and 3-year follow-up, and more than 50% of the psychosis diagnoses could be attributed to cannabis use. On the additive scale, the effect of cannabis use was much stronger in those with a baseline diagnosis of psychotic disorder (risk difference, 54.7%) than in those without (risk difference, 2.2%; p for interaction = 0.001). Results confirm previous suggestions that cannabis use increases the risk of both the incidence of psychosis in psychosis-free persons and a poor prognosis for those with an established vulnerability to psychotic disorder. Am J Epidemiol 2002;156:319–27.

cannabis; drug utilization; psychoses, substance-induced; psychotic disorders; schizophrenia

Abbreviations: Abbreviations: BPRS, Brief Psychiatric Rating Scale; CI, confidence interval; CIDI, Composite International Diagnostic Interview; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; OR, odds ratio; T1, time 1 (between baseline and 1997); T2, time 2 (between 1997 (T1) and 1999).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
V. S. Harder, E. A. Stuart, and J. C. Anthony
Adolescent Cannabis Problems and Young Adult Depression: Male-Female Stratified Propensity Score Analyses
Am. J. Epidemiol., August 6, 2008; (2008) kwn184v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
J. E. Houston, J. Murphy, G. Adamson, M. Stringer, and M. Shevlin
Childhood Sexual Abuse, Early Cannabis Use, and Psychosis: Testing an Interaction Model Based on the National Comorbidity Survey
Schizophr Bull, May 1, 2008; 34(3): 580 - 585.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
J. Macleod
Cannabis use and psychosis: the origins and implications of an association
Advan. Psychiatr. Treat., November 1, 2007; 13(6): 400 - 411.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. Archie, B. R. Rush, N. Akhtar-Danesh, R. Norman, A. Malla, P. Roy, and R. B. Zipursky
Substance Use and Abuse in First-Episode Psychosis: Prevalence Before and After Early Intervention
Schizophr Bull, November 1, 2007; 33(6): 1354 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. WEISER, J. VAN OS, A. REICHENBERG, J. RABINOWITZ, D. NAHON, E. KRAVITZ, G. LUBIN, M. SHMUSHKEVITZ, H. Y. KNOBLER, S. NOY, et al.
Social and cognitive functioning, urbanicity and risk for schizophrenia
The British Journal of Psychiatry, October 1, 2007; 191(4): 320 - 324.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. McCabe, M. Saidi, and S. Priebe
Patient-reported outcomes in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s21 - s28.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. Junginger and K. Claypoole

Psychiatr Serv, October 1, 2006; 57(10): 1512 - 1512.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
L. Hides, S. Dawe, D. J. Kavanagh, and R. M. Young
Psychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study
The British Journal of Psychiatry, August 1, 2006; 189(2): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
N. J. WILES, S. ZAMMIT, P. BEBBINGTON, N. SINGLETON, H. MELTZER, and G. LEWIS
Self-reported psychotic symptoms in the general population: Results from the longitudinal study of the British National Psychiatric Morbidity Survey
The British Journal of Psychiatry, June 1, 2006; 188(6): 519 - 526.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. SPAUWEN, L. KRABBENDAM, R. LIEB, H.-U. WITTCHEN, and J. VAN OS
Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness
The British Journal of Psychiatry, June 1, 2006; 188(6): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. M Fergusson, R. Poulton, P. F Smith, and J. M Boden
Cannabis and psychosis
BMJ, January 21, 2006; 332(7534): 172 - 175.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Sareen, B. J. Cox, T. O. Afifi, R. de Graaf, G. J. G. Asmundson, M. ten Have, and M. B. Stein
Anxiety Disorders and Risk for Suicidal Ideation and Suicide Attempts: A Population-Based Longitudinal Study of Adults
Arch Gen Psychiatry, November 1, 2005; 62(11): 1249 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
B. GREEN, R. YOUNG, and D. KAVANAGH
Cannabis use and misuse prevalence among people with psychosis
The British Journal of Psychiatry, October 1, 2005; 187(4): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
J. Addington
Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed
Evid. Based Ment. Health, August 1, 2005; 8(3): 87 - 87.
[Full Text] [PDF]


Home page
Schizophr BullHome page
C. Henquet, R. Murray, D. Linszen, and J. van Os
The Environment and Schizophrenia: The Role of Cannabis Use
Schizophr Bull, July 1, 2005; 31(3): 608 - 612.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
D. M. Semple, A. M. McIntosh, and S. M. Lawrie
Cannabis as a risk factor for psychosis: systematic review
J Psychopharmacol, March 1, 2005; 19(2): 187 - 194.
[Abstract] [PDF]


Home page
BMJHome page
C. Henquet, L. Krabbendam, J. Spauwen, C. Kaplan, R. Lieb, H.-U. Wittchen, and J. van Os
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
BMJ, January 1, 2005; 330(7481): 11.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. van Os, C. B. Pedersen, and P. B. Mortensen
Confirmation of Synergy Between Urbanicity and Familial Liability in the Causation of Psychosis
Am J Psychiatry, December 1, 2004; 161(12): 2312 - 2314.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
L. C. Johns, M. Cannon, N. Singleton, R. M. Murray, M. Farrell, T. Brugha, P. Bebbington, R. Jenkins, and H. Meltzer
Prevalence and correlates of self-reported psychotic symptoms in the British population
The British Journal of Psychiatry, October 1, 2004; 185(4): 298 - 305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Weiser, A. Reichenberg, I. Grotto, R. Yasvitzky, J. Rabinowitz, G. Lubin, D. Nahon, H. Y. Knobler, and M. Davidson
Higher Rates of Cigarette Smoking in Male Adolescents Before the Onset of Schizophrenia: A Historical-Prospective Cohort Study
Am J Psychiatry, July 1, 2004; 161(7): 1219 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
N. D. Veen, J.-P. Selten, I. van der Tweel, W. G. Feller, H. W. Hoek, and R. S. Kahn
Cannabis Use and Age at Onset of Schizophrenia
Am J Psychiatry, March 1, 2004; 161(3): 501 - 506.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
L. Arseneault, M. Cannon, J. Witton, and R. M. Murray
Causal association between cannabis and psychosis: examination of the evidence
The British Journal of Psychiatry, February 2, 2004; 184(2): 110 - 117.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. M Rey and C. C Tennant
Cannabis and mental health
BMJ, November 23, 2002; 325(7374): 1183 - 1184.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.